Loading stock data…
$0.81-0.04 (-4.51%)
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
IRIDEX Corporation in the Healthcare sector is trading at $0.81 with a market capitalization of $12M. Wall Street consensus targets $2.75 (1 analysts), implying a +239.5% move over the next 12 months. The stock is currently near its 52-week low of $0.61, remaining 24.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $12.57M↑ | $11.80M↓ | $14.72M↑ | $12.48M↓ | $13.57M |
| Gross Profit | $4.30M↓ | $4.74M↓ | $5.48M↑ | $4.01M↓ | $4.68M |
| Operating Income | -$1.03M↓ | -$324,000↓ | -$15,000↑ | -$1.41M↓ | -$940,000 |
| Net Income | -$1.27M↓ | -$524,000↓ | -$184,000↑ | -$1.57M↓ | -$994,000 |
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo...